Skip to main content

Table 1 Baseline characteristics of 40 patients with IgG4-related aortitis/periaortitis and periarteritis

From: Clinical course after corticosteroid therapy in IgG4-related aortitis/periaortitis and periarteritis: a retrospective multicenter study

      

Location of vascular lesion

Luminal dilatation before Tx

  

Risk factor of arteriosclerosis

Initial PSL Tx (mg/day)

 

Follow-up

IgG

IgG4

IgE

CRP

Extravascular lesions

  

Patient

(mo)

(mg/dl)

(mg/dl)

(IU/ml)

(mg/dl)

 

Symptoms

 

1

204

1,894

128

543

6.2

AA

(−)

La, Sa

abdo P, fever

(−)

30

2

120

2,840

693

468

0.1

AA

(−)

Sa

(−)

DM, Sm

30

3

96

5,970

3,100

259

1.56

AA

(−)

La, Sa, Hy, Pa

malaise

DM, HT

40

4

78

2,140

557

266

<0.10

AA, IA

(+)

La, Sa

(−)

DL, Sm

50

5

70

1,500

173

151

0.3

IA, SMA

(−)

Pa, RF

abdo P

DM, HT, DL, Sm

20

6

63

2,970

1,330

419

<0.10

AA

(−)

La, Sa, Pa, Ki, RF

malaise

DM, HT, DL, Sm

40

7

63

2,130

715

253

<0.10

IA

(−)

La, Sa

(−)

DM, DL, Sm

40

8

63

2,731

269

975

0.6

AA

(−)

Sa, RF

(−)

DM, HT, DL, Sm

30

9

57

1,790b

105b

212b

1.5b

AA, IA

(+)

Hy, Lu, Pa, Ly

(−)

DL

40

10

54

2,570

1,420

345

0.3

AA, IA

(+)

Pa

(−)

DM, HT

20

11

48

2,950

1,540

7.9

<0.1

AA

(−)

Sa, Bi, Pa, Pr

(−)

DM

30

12

43

1,487

196

447

0.6

AA, IA

(−)

RF

abdo P

DM, HT, DL, Sm

0

13

37

2,563

1,330

283

0.09

AA

(−)

Sa, Ki

pollakiuria

DL, Sm

45

14

35

2,319

734

542

1.19

TA, AA

(−)

Sa, Pa, Ki

(−)

DM, DL

40

15

34

1,458

158

452

0.22

AA

(−)

Sa, Ly

(−)

DM, HT, DL, Sm

30

16

27

2,081

870

1,285

0.0

AA, IA

(−)

Sa, RF, Pr

(−)

DM, HT

20

17

27

1,756

408

513

0.2

AA, IA

(−)

Sa, Pa, Ki

(−)

DM, HT, DL, Sm

20

18

27

1,762

144

24

0.32

AA, IA

(+)

Pa

(−)

DL, Sm

20

19

25

2,024

292

1,400

0.14

AA

(−)

Pa, RF

(−)

DM, HT, Sm

40

20

24

2,262

299

443

<0.05

AA

(−)

(−)

(−)

HT

0

21

24

2,184

236

365

0.3

AA

(+)

La, Sa

fever

DM, HT, DL

30

22

22

3,484

1,896

247

0.0

AA

(−)

La, Sa, Pa, Ki, Ly

(−)

Sm

35

23

15

4,171

2,120

<20

0.32

AA, IA

(−)

La, Sa, Ki

(−)

DM, HT, Sm

40

24

13

1,837

261

687

0.06

IA

(−)

RF

(−)

HT, DL

30

25

13

1,454

196

350

0.13

AA, IA

(−)

(−)

abdo P

Sm

15

26

10

2,213

455

NA

0.56

AA, IA

(−)

Sa, Ki

arthralgia

HT, DL, Sm

40

27

10

3,120

1,020

1,760

1.5

AA, IA, IMA

(−)

La, Sa

hoarseness, fever

Sm

30

28

9

2,936

1,070

17

0.0

TA, AA, IA

(−)

La, Sa, Pa, Ki

thirst

DM, DL, Sm

40

29

9

10,121

2,500

<20

0.37

IA

(+)

Pa, Ki, Ly

malaise

DM

50

30

9

1,200

147

NA

2.94

AA, IA

(−)

(−)

fever, malaise

DM, HT

30

31

8

1,475

210

111

0.3

IA

(−)

Sa

(−)

(−)

40

32

4

2,938

1,520

48

0.1

AA

(−)

La, Sa, Ki, RF

(−)

Sm

30

33

4

1,463

672

216

0.13

AA

(−)

Sa, Pl, Ca

(−)

Sm

0

34

3

2,439

782

703

0.2

AA, IA

(−)

La, Ki, RF

(−)

DM, DL, Sm

20

35

3

2,244

503

311

0.0

AA, IA

(−)

Ki

edema

(−)

30

36

2

1,950

711

737

0.0

AA

(−)

La, Sa, Lu, Ki

(−)

Sm

35

37

2

1,328

106

19

0.28

AA, IA

(+)

RF

(−)

DL

0

38

1

4,420

2,680

174

0.1

IA

(−)

La, Sa, Bi, Pa, Ki, Ne

diarrhea

Sm

50

39

1

2,276

835

<20

0.91

IA

(−)

Sa

(−)

HT

15

40

1

1,600

206

212

0.38

AA

(−)

(−)

abdo P, malaise

Sm

30

  1. AA, Abdominal aorta; abdo, Abdominal; Bi, Bile tract; Ca, Pericarditis; CRP, C-reactive protein; DL, Dyslipidemia; DM, Diabetes mellitus; F, Female; HT, Hypertension; Hy, Hypophysitis; IA, Iliac artery; IgE, Serum immunoglobulin E at diagnosis; IgG, Serum immunoglobulin G at diagnosis; IgG4, Serum immunoglobulin G4 at diagnosis; IMA, Inferior mesenteric artery; Ki, IgG4-related kidney disease; La, Lacrimal gland, Lu, Lung; Ly, Lymph node; M, Male; Mo, month; NA, Not available; Ne, Nerve; P, Pain; Pa, Pancreas; Pl, Pleuritis; Pr, P rostate; PSL, Prednisolone; RF, Retroperitoneal fibrosis; Sa, Salivary gland; Sm, Past or current smoking; SMA, Superior mesenteric artery; TA, Thoracic aorta; Tx, Treatment. bValue under corticosteroid therapy.